-inc-logo-1200x675.png){kind=logo}
WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) saw an uptick in trading volume on Wednesday . Approximately 111,093 shares were traded during trading, an increase of 52% from the previous session’s volume of 72,933 shares.The stock last traded at $10.20 and had previously closed at $9.90.
WuXi Biologics (Cayman) Stock Performance
The firm has a 50 day moving average of $8.98 and a 200-day moving average of $9.10.
WuXi Biologics (Cayman) Company Profile
WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.
The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.
Featured Stories
- Five stocks we like better than WuXi Biologics (Cayman)
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
- Why the Landlord of the AI Boom Could Outlast the Chipmakers
- AST SpaceMobile’s Latest BlueBird Launch Raises the Stakes Ahead of Q2 Earnings
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
